Reported 1 day ago
Walgreens is facing significant challenges in the pharmacy retail sector, leading to its decision to go private with a buyout from Sycamore Partners, expected to close in late 2025. Investors can anticipate a guaranteed cash payout of $11.45 per share, but the stock offers little long-term potential as it exits the public market. There's an additional possible gain from the upcoming sale of its medical clinic business, which may provide shareholders with extra value, though both the timing and the actual proceeds are uncertain.
Source: YAHOO